Evidence conflicts over efficacy of monoclonal antibodies in severe COVID

Retrieved on: 2021-02-26 21:33:45

Tags for this article:

Click the tags to see associated articles and topics

Evidence conflicts over efficacy of monoclonal antibodies in severe COVID. View article details on hiswai:

Excerpt

Both monoclonal antibodies showed effectiveness in improving 90-day survival, time to ICU and hospital release, and World Health Organization ...

Article found on: www.cidrap.umn.edu